Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.57 -0.76%
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royalty Pharma acquires royalty stake in AstraZeneca's cliramitug
- Community West Bancshares (CWBC) Misses Q2 EPS by 20c
- American Express down 2% in premarket trade after Q2 revenue miss offsets EPS beat
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
